期刊文献+

BHLHB2参与人胰腺癌细胞的迁徙、凋亡及EMT 被引量:3

BHLHB2 participates in cell migration,cell apoptosis and EMT in human pancreatic cancer
下载PDF
导出
摘要 目的进一步研究前期实验结果证明的人胰腺癌新颖的独立预后因子BHLHB2在人胰腺癌细胞中的相关分子生物学功能。方法应用siRNA干扰技术,在人胰腺癌细胞株SU86.86中使BHLHB2表达沉寂,应用迁徙实验研究BHLHB2与细胞迁徙的关系;应用更生霉素(ACT-D)诱导细胞凋亡,研究BHLHB2与细胞凋亡的关系;应用Western blot方法研究BHLHB2与EMT的相关性。结果人胰腺癌细胞BHLHB2表达沉寂后,细胞的迁徙明显增快。应用ACT-D进行凋亡诱导,BHLHB2表达沉寂后与对照组相比,发生凋亡的细胞数目显著增加(10μg/L,P<0.05;100μg/L,P<0.05)。Western blot结果表明,BHLHB2表达沉寂后可显著降低E-cadherin的表达(P<0.01)。结论 BHLHB2与人胰腺癌细胞的迁徙、细胞凋亡及EMT密切相关。 Objective To further explore BHLHB2 related molecular biology functions,which was proved to be a novel and independent prognostic marker in pancreatic ductal adenocarcinoma.Methods Knock-down of BHLHB2 in pancreatic cancer cell line-SU86.86 was achieved by siRNA treatment.Migration essay was performed to research the relationship between BHLHB2 and cell migration.The proliferation assay induced by ACT-D to explore BHLHB2 roles in cell apoptosis.Relationship between BHLHB2 and EMT was analyzed using Western blot.Results BHLHB2 silencing with RNAi significantly promote cell migrate,and induced cell apoptosis by Actinomycin D(ACT-D)(10 μg/L,increased 1.32 fold,P0.05;100 μg/L,increased 1.41 fold,P0.05).By Western blot,BHLHB2 silencing significantly deduced E-cadherin expression(decreased 1.28 fold,P0.01),which implicated that BHLHB2 was correlated with epithelial mesenchymal transform(EMT).Conclusions BHLHB2 closely associated with cell migration,cell apoptosis and EMT in human pancreatic cancer.
出处 《基础医学与临床》 CSCD 北大核心 2012年第3期300-304,共5页 Basic and Clinical Medicine
关键词 胰腺癌 细胞凋亡 细胞迁徙 pancreatic cancer cell apoptosis cell migration
  • 相关文献

参考文献20

  • 1Jemal ASR,Ward E,Murray T,et al.Cancer statistics[J] CA Cancer J Clin,2006,56:106-130.
  • 2Kleeff J M C,Friess H,Büchler MW.Pancreatic cancer:from bench to 5-year survival[J] Pancreas,2006,33:111-118.
  • 3Giatromanolaki A,Koukourakis MI,Sivridis E,et al.DEC1(STRA13)protein expression relates to hypoxia-in-ducible factor 1-alpha and carbonic anhydrase-9 overexpres-sion in non-small cell lung cancer[J] J Pathol,2003,200:222-228.
  • 4Li Y,Zhang H,Xie M,et al.Abundant expression ofDec1/stra13/sharp2 in colon carcinoma:its antagonizingrole in serum deprivation-induced apoptosis and selectiveinhibition of procaspase activation[J] Biochem J,2002,367:413-422.
  • 5Chakrabarti J,Turley H,Campo L,et al.The transcriptionfactor DEC1(stra13,SHARP2)is associated with the hy-poxic response and high tumour grade in human breastcancers[J] Br J Cancer,2004,91:954-958.
  • 6Sato FBU,Kawamoto T,Fujimoto K,et al.Basic-helix-loop-helix(bHLH)transcription factor DEC2 negativelyregulates vascular endothelial growth factor expression[J] Genes Cells,2008,13:131-144.
  • 7Noshiro MUE,Kawamoto T,Sato F,et al.Liver X recep-tors(LXRalpha and LXRbeta)are potent regulators for he-patic Dec1 expression[J] Genes Cells,2009,14:29-40.
  • 8Guillaumond F L S,Dulong S,Grechez-Cassiau A,et al.Altered Stra13 and Dec2 circadian gene expression in hy-poxic cells[J] Biochem Biophys Res Commun,2008,369:1184-1189.
  • 9Ehata SHA,Hayashi M,Aburatani H,et al.Transforminggrowth factor-beta promotes survival of mammary carcinomacells through induction of antiapoptotic transcription factorDEC1[J] Cancer Res,2007,67:9694-9703.
  • 10Lundgren K N B,Landberg G.Hypoxia,Snail and incom-plete epithelial-mesenchymal transition in breast cancer[J] Br J Cancer,2009,101:1769-1781.

同被引文献19

  • 1Salehi F,Kovacs K,Scheithauer BW,et al.Pituitary tumor-transforming gene in endocrine and other neoplasms:a review and update[J] .Endocr Relat Cancer,2008,15:721-743.
  • 2Li H,Yin C,Zhang B,et al.PTTG1 promotes migration and invasion of human non-small cell lung cancer cells and is modulated by miR-186[J] .Carcinogenesis,2013,34:2145-2155.
  • 3Thiery JP.Epithelial-mesenchymal transitions in development and pathologies[J] .Curr Opin Cell Biol,2003,15:740-746.
  • 4Zhang X,Horwitz GA,Prezant TR,et al.Structure,expression,and function of human pituitary tumor-transforming gene (PTTG)[J] .Mol Endocrinol,1999,13:156-166.
  • 5Hamid T,Malik MT,Kakar SS.Ectopic expression of PT-TG1/securin promotes tumorigenesis in human embryonic kidney cells[J] .Mol Cancer,2005,4:3.
  • 6Ishikawa H,Heaney AP,Yu R,et al.Human pituitary tumor-transforming gene induces angiogenesis[J] .J Clin Endocrinol Metab,2001,86:867-874.
  • 7McCabe C J,Boelaert K,Tannahill LA,et al.Vascular endothelial growth factor,its receptor KDR/Flk-1,and pituitary tumor transforming gene in pituitary tumors[J] .J Clin Endocrinol Metab,2002,87:4238-4244.
  • 8Shah PP,Kakar SS.Pituitary tumor transforming gene induces epithelial to mesenchymal transition by regulation of Twist,Snail,Slug,and E-cadherin[J] .Cancer Lett,2011,311:66-76.
  • 9Thompson EW,Newgreen DF,Tarin D.Carcinoma invasion and metastasis:a role for epithelial-mesenchymal transition[J] ? Cancer Res,2005,65:5991-5995.
  • 10Aamodt R,Bondi J,Andersen SN,et al.The prognostic impact of protein expression of E-cadherin-catenin complexes differs between rectal and colon carcinoma[J] .Gastroenterol Res Pract,2010,2010:1-8.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部